Bridgeway Capital Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-193,500
| Closed | -$602K | – | 1396 |
|
|
2022
Q1 | $602K | Buy |
193,500
+150,000
| +345% | +$467K | 0.01% | 894 |
|
|
2021
Q4 | $147K | Buy |
+43,500
| New | +$147K | ﹤0.01% | 1187 |
|
|
2020
Q4 | – | Sell |
-98,224
| Closed | -$711K | – | 1378 |
|
|
2020
Q3 | $711K | Sell |
98,224
-399,300
| -80% | -$2.89M | 0.02% | 779 |
|
|
2020
Q2 | $1.74M | Buy |
497,524
+342,524
| +221% | +$1.2M | 0.04% | 483 |
|
|
2020
Q1 | $229K | Sell |
155,000
-122,600
| -44% | -$181K | 0.01% | 1017 |
|
|
2019
Q4 | $544K | Buy |
+277,600
| New | +$544K | 0.01% | 946 |
|